SCIENTIFIC HUB

Follow the evidence.

SCIENTIFIC LITERATURE · PPR

The importance of early biomarkers in the identification of neurodegenerative disorders

· 2025-07-10

DOI: 10.12688/f1000research.163212.1

Check source for accessPreprintOriginal source ↗

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

In this datanote we presented the data of 31 iRBD (idiopathic Rapid eye movement (REM) sleep Behaviour Disorder) patients studied throughout three years to assess their eventual phenoconversion to Parkinson’s disease and other established neurodegenerative conditions. iRBD is a prodromal condition involved in the development of neurological pathologies such as Parkinson’s disease. In a previous study we evaluated transcription factor mRNA levels in CD4+ T cells as predictive biomarkers of phenoconversion in iRBD. We demonstrated that among the transcription factors mRNA levels analysed, STAT1, GATA3 and FOXP3 mRNA levels in CD4+ T cells may be used to predict phenoconversion.

Scientific assessment

01

Research question

Assess the question within the original study’s scope.

02

Methods & sample

Check the source article for study design and sample details.

03

Key findings

An editorially approved findings summary is not yet published for this record.

04

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.